Search research articles
Contact Us
Filters
Showing results (1-10 of 135) with videos related to
Page
of 14
Sort By:
Nature Biomedical Engineering
|
May 13, 2020
Evolving peptides for oral intake
David J Brayden
Therapeutic Delivery
|
November 9, 2016
The challenges and future of oral drug delivery: An interview with David Brayden
David J Brayden
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 25, 2022
Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials
David J Brayden
Drug Discovery Today
|
December 4, 2003
Controlled release technologies for drug delivery
David J Brayden
Journal of Pharmaceutical Sciences
|
August 30, 2020
Per Artursson's Major Contributions to the Caco-2 Cell Literature in Pharmaceutical Sciences
David J Brayden
Therapeutic Delivery
|
September 26, 2017
Progress in the formulation and delivery of somatostatin analogs for acromegaly
Sarinj Fattah, David J Brayden
Nanomedicine (London, England)
|
June 27, 2015
Development of nanotoxicology: implications for drug delivery and medical devices
Sourav Bhattacharjee, David J Brayden
Expert Opinion on Drug Discovery
|
October 27, 2020
Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients
Sourav Bhattacharjee, David J Brayden
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 1, 2021
Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays
David J Brayden, Vivien Stuettgen
The AAPS Journal
|
June 26, 2014
Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative
David J Brayden, Edwin Walsh
Page
of 14
Search research articles
Search
Showing results (1-10 of 135) with videos related to
Sort By:
Page
of 14
Nature Biomedical Engineering
|
May 13, 2020
Evolving peptides for oral intake
David J Brayden
Therapeutic Delivery
|
November 9, 2016
The challenges and future of oral drug delivery: An interview with David Brayden
David J Brayden
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 25, 2022
Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials
David J Brayden
Drug Discovery Today
|
December 4, 2003
Controlled release technologies for drug delivery
David J Brayden
Journal of Pharmaceutical Sciences
|
August 30, 2020
Per Artursson's Major Contributions to the Caco-2 Cell Literature in Pharmaceutical Sciences
David J Brayden
Therapeutic Delivery
|
September 26, 2017
Progress in the formulation and delivery of somatostatin analogs for acromegaly
Sarinj Fattah, David J Brayden
Nanomedicine (London, England)
|
June 27, 2015
Development of nanotoxicology: implications for drug delivery and medical devices
Sourav Bhattacharjee, David J Brayden
Expert Opinion on Drug Discovery
|
October 27, 2020
Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients
Sourav Bhattacharjee, David J Brayden
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 1, 2021
Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays
David J Brayden, Vivien Stuettgen
The AAPS Journal
|
June 26, 2014
Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative
David J Brayden, Edwin Walsh
Page
of 14